Nation and world news briefs
AstraZeneca cleared by US regulators to resume vaccine trialAstraZeneca Plc, the U.K. drugmaker developing a coronavirus vaccine with the University of Oxford, has been cleared by U.S. regulators to restart a trial halted in the country for more than a month on concerns about a volunteer who became ill, according to a person familiar with the decision.The person asked not to be identified because the information isn’t public.A decision to allow the study to resume would remove a significant impediment for AstraZeneca and Oxford as they try to get their coronavirus shot across the line. They ar...
Tribune News Service
GM unveils all-electric Hummer that costs $112,595
DETROIT — The 2022 GMC Hummer EV has arrived.General Motors Co. virtually unveiled the $112,595 “Edition 1” of the off-roading electric supertruck Tuesday across multiple platforms, including Game One of the World Series and NBC’s “The Voice.”The Hummer, known a decade ago as a gas-guzzling Goliath, has been reborn with a soundless, fully electric system. But its size and stature on the road remain. It’s one of the 20 battery-powered vehicles GM plans to feature by 2023 and it will be built right here in Detroit at the newly named Factory Zero Detroit-Hamtramck Assembly Center starting in fall...
The Detroit News
GM to invest billions in Michigan plants, converts another plant to EV
DETROIT — General Motors said Tuesday it is investing $2 billion in six U.S. assembly plants and will be converting its Spring Hill, Tenn., assembly plant to become the company’s third factory to build electric vehicles.As part of that, GM said it will build the Cadillac Lyriq all-electric SUV at Spring Hill Assembly. GM presently builds the Cadillac XT5, XT6 SUVs and the GMC Acadia SUV at Spring Hill. It also makes a variety of engines used across GM’s lineup.GM said the plant will continue to make the XT5 and XT6 plus the electric Lyriq, which goes on sale first in China and then in the Unit...
Detroit Free Press
Commentary: In the race for a COVID-19 vaccine, how do we balance risk and safety?
The great race for a COVID-19 vaccine has more than 130 medicines in development, with 40 being tested on humans, of which 10 are in large, phase 3 trials. The U.S. Government has invested about $11 billion in Operation Warp Speed, making advance purchases from Moderna, Johnson & Johnson, Pfizer/BioNTech, Sanofi/GlaxoSmithKline, Novavax and AstraZeneca — betting that at least some will be soon approved by regulators as “safe and effective” vaccines.No matter your Twitter feed, “vaccines have been one of the greatest public health tools to prevent disease,” as The New York Times explained in Ja...
Ford warns of fire, loss of control with 2020 Escape, Mustang Shelby, Transit Connect
Ford Motor Co. warned Monday that certain 2019-2020 Ford Transit Connect vans have an engine flaw that could create fire risk while certain 2020 Ford Escape SUVs have tire pressure monitoring flaws that could lead to loss of control.Both vehicles are the subject of recalls, along with the high-performance of the Mustang Shelby GT350 and Mustang Shelby GT500 for its light system.The company said it is unaware of any accident or injury related to these situations.Transit ConnectCertain Transit Connect vehicles with the 2.5L engine have a software calibration issue that fails to keep the engine a...
Detroit Free Press
Bankrupt Mallinckrodt may still be expected to help shoulder nuclear cleanup costs
ST. LOUIS — Two sets of nuclear waste complaints against Mallinckrodt have been thrown into question in a two-week span, while the company restructures in bankruptcy court.Facing a wave of lawsuits and a $1.6 billion settlement stemming from its role in the national opioid crisis, the company with deep St. Louis roots filed for protection from creditors on Monday.While industry analysts have focused on Mallinckrodt’s future as a drugmaker, the company also faces potential liabilities for work a predecessor company, St. Louis-based Mallinckrodt Chemical Works, performed decades ago, when it pro...
St. Louis Post-Dispatch
Pfizer says coronavirus vaccine won't be ready until Thanksgiving — at the earliest
Pfizer Inc., one of the many pharmaceutical companies racing to develop a coronavirus vaccine, said it hopes to have a treatment authorized for emergency use by the end of the year.CEO Albert Bourla in an open letter published Friday revealed that while scientists are working quickly to develop a vaccine, that it would not be ready by Election Day — a claim that has been repeatedly made by President Donald Trump. He added that the earliest the company would seek authorization from the Food and Drug Administration would be the third week of November.Pfizer expects to have preliminary numbers by...
New York Daily News
Biden or Trump? Autoworkers back their guy
FLINT, Mich. — Inside General Motors Co.’s Flint Assembly plant, autoworkers are staking out both sides of the aisle — a reflection of the political division cleaving the Michigan electorate less than 20 days before the election.Richard Incrocci says he loves his union as he stands in the parking lot of the United Auto Workers Local 598 hall that proudly displays Biden/Harris signs out front. So does his co-worker Lori Welch.But they are divided over who should sit in the Oval Office the next four years, who could lead the country in the wake of the COVID-19 pandemic, who’s best equipped to st...
The Detroit News
GM's Detroit-Hamtramck Assembly plant renamed 'Factory ZERO' amid shift to all-electric
DETROIT — The iconic General Motors factory that straddles two cities is getting a new moniker as GM turns it into its most modern plant in the country.Detroit-Hamtramck Assembly will now be Factory ZERO, serving as the “launchpad” for GM’s multi-brand EV strategy, GM said Friday.“Factory ZERO is the next battleground in the EV race and will be GM’s flagship assembly plant in our journey to an all-electric future,” said Gerald Johnson, GM executive vice president of Global Manufacturing. “The electric trucks and SUVs that will be built here will help transform GM and the automotive industry.”T...
Detroit Free Press
Seattle-area man is the third person in the US confirmed to have been infected twice with coronavirus
SEATTLE — The Seattle-area nursing home resident first tested positive for the novel coronavirus in early March. He spent more than 40 days in the hospital with fever, pneumonia and difficulty breathing before testing negative multiple times and being discharged.Then, nearly five months later, he got sick again with COVID-19.Now, genetic testing by a team of Seattle physicians and scientists has revealed that sexagenarian’s second bout of the illness caused by the coronavirus in July wasn’t a relapse but a new infection with a slightly different variant of the virus.The patient is only the thi...
The Seattle Times